Vortex Pharma Solution ApS — Credit Rating and Financial Key Figures

CVR number: 43009672
Hjortevænget 32, 2880 Bagsværd

Income statement (kDKK)

2022
2023
2024
Fiscal period length121212
Net sales
Gross profit319.11-58.99613.16
Costs of management-73.29- 149.42- 217.81
Costs of distribution-18.85-84.68-80.90
EBIT226.98- 293.08314.45
Other financial expenses-1.63-2.52-2.76
Pre-tax profit225.35- 295.60311.69
Income taxes-52.06-9.05
Net earnings173.28- 295.60302.63

Assets (kDKK)

2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors166.80193.84
Current other receivables0.01
Short term receivables total166.80193.840.01
Cash and bank deposits288.4185.93514.55
Cash and cash equivalents288.4185.93514.55
Balance sheet total (assets)455.21279.77514.55

Equity and liabilities (kDKK)

2022
2023
2024
Share capital40.0040.0040.00
Shares repurchased75.00
Other reserves98.28- 196.64105.99
Retained earnings- 173.28295.60- 302.63
Profit of the financial year173.28- 295.60302.63
Shareholders equity total213.28- 156.64145.99
Non-current liabilities total
Current trade creditors5.080.122.09
Current owed to group member15.50149.34102.29
Other non-interest bearing current liabilities221.33286.95264.18
Current liabilities total241.92436.41368.56
Balance sheet total (liabilities)455.21279.77514.55
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.